AU8305491A - Novel immunosuppressant peptides - Google Patents

Novel immunosuppressant peptides

Info

Publication number
AU8305491A
AU8305491A AU83054/91A AU8305491A AU8305491A AU 8305491 A AU8305491 A AU 8305491A AU 83054/91 A AU83054/91 A AU 83054/91A AU 8305491 A AU8305491 A AU 8305491A AU 8305491 A AU8305491 A AU 8305491A
Authority
AU
Australia
Prior art keywords
novel immunosuppressant
peptides
immunosuppressant peptides
novel
immunosuppressant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU83054/91A
Inventor
Thomas S Arrhenius
Federico C.A. Gaeta
Howard M. Grey
Michael F Powell
Alessandro D Sette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Cytel Corp
Original Assignee
Cytel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytel Corp filed Critical Cytel Corp
Publication of AU8305491A publication Critical patent/AU8305491A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU83054/91A 1990-08-01 1991-07-29 Novel immunosuppressant peptides Abandoned AU8305491A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US56061590A 1990-08-01 1990-08-01
US65448291A 1991-02-12 1991-02-12
US560615 1995-11-20
US654482 1996-05-28

Publications (1)

Publication Number Publication Date
AU8305491A true AU8305491A (en) 1992-03-02

Family

ID=27072401

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83054/91A Abandoned AU8305491A (en) 1990-08-01 1991-07-29 Novel immunosuppressant peptides

Country Status (6)

Country Link
AU (1) AU8305491A (en)
IE (1) IE912701A1 (en)
IL (1) IL99008A0 (en)
MX (1) MX9100454A (en)
PT (1) PT98501A (en)
WO (1) WO1992002543A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005011A1 (en) * 1991-08-29 1993-03-18 Sandoz Ltd. Novel immunosuppressants
US7611713B2 (en) 1993-03-05 2009-11-03 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide compositions
US7252829B1 (en) 1998-06-17 2007-08-07 Idm Pharma, Inc. HLA binding peptides and their uses
US9340577B2 (en) 1992-08-07 2016-05-17 Epimmune Inc. HLA binding motifs and peptides and their uses
US5405940A (en) 1992-08-31 1995-04-11 Ludwig Institute For Cancer Research Isolated nonapeptides derived from MAGE genes and uses thereof
US6222012B1 (en) 1992-08-31 2001-04-24 Ludwig Institute For Cancer Research Isolated nonapeptides presented by HLA molecules, and uses thereof
ES2225824T3 (en) 1992-08-31 2005-03-16 Ludwig Institute For Cancer Research ISOLATED NONAPEPTIDE DERIVED FROM GEN MAGE-3 AND PRESENTED BY HLA-A1, AND ITS USES.
US5589458A (en) * 1992-11-13 1996-12-31 Thomas Jefferson University Compounds that inhibit T cell proliferation and methods for using the same
US5385918A (en) * 1993-02-09 1995-01-31 Miles Inc. Aminomethylene-peptides as immunosuppressants
US6413935B1 (en) 1993-09-14 2002-07-02 Epimmune Inc. Induction of immune response against desired determinants
DK0735893T3 (en) * 1993-09-14 2009-03-09 Pharmexa Inc PAN DR-binding peptides to enhance the immune response
US6509165B1 (en) 1994-07-08 2003-01-21 Trustees Of Dartmouth College Detection methods for type I diabetes
AU6099496A (en) * 1995-06-07 1996-12-30 G.D. Searle & Co. Pipecolic acid derivatives of proline threonine amides usefu l for the treatment of rheumatoid arthritis
WO1997026538A1 (en) * 1996-01-19 1997-07-24 Virginia Mason Research Center Allele-specific peptide epitope strategy for vaccine development
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
WO1997046578A1 (en) 1996-06-07 1997-12-11 Zeneca Limited Peptide derivatives
GB9621836D0 (en) * 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9624562D0 (en) 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives
US6413517B1 (en) 1997-01-23 2002-07-02 Epimmune, Inc. Identification of broadly reactive DR restricted epitopes
FR2763071B1 (en) * 1997-05-07 2003-05-16 Centre Nat Rech Scient PEPTIDE ANALOGS AND THEIR USES IN PARTICULAR IN PHARMACEUTICAL COMPOSITIONS AND FOR DIAGNOSIS
ES2527760T3 (en) 1998-07-23 2015-01-29 Yeda Research And Development Co., Ltd. Treatment of Crohn's disease with copolymer 1 and polypeptides
IL140592A0 (en) * 1998-07-23 2002-02-10 Harvard College Synthetic peptides and methods of use for autoimmune disease therapies
IL141021A0 (en) 1998-07-23 2002-02-10 Yeda Res & Dev Treatment of autoimmune conditions with copolymer 1 and related copolymers
US6800287B2 (en) 1998-09-25 2004-10-05 Yeda Research And Development Co., Ltd. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
CA2355400A1 (en) * 1998-11-12 2000-05-18 Yeda Research And Development Co., Ltd. Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating gvhd and hvgd
US7053043B1 (en) 1999-07-23 2006-05-30 Yeda Research And Development Co.Ltd. Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating GVHD and HVGD
CA2386341A1 (en) 1999-11-18 2001-05-25 Epimmune Inc. Heteroclitic analogs and related methods
US7026443B1 (en) 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
US7462354B2 (en) 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
US7022663B2 (en) 2000-02-18 2006-04-04 Yeda Research And Development Co., Ltd. Oral, nasal and pulmonary dosage formulations of copolymer 1
US20020077278A1 (en) 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
WO2002076503A1 (en) 2000-06-20 2002-10-03 Mayo Foundation For Medical Education And Research Treatment of central nervous system diseases by antibodies against glatiramer acetate
AU2002362445B2 (en) 2001-10-03 2006-09-21 President And Fellows Of Harvard College Copolymers for suppression of autoimmune diseases, and methods of use
CN1308683C (en) 2001-12-04 2007-04-04 特瓦制药工业有限公司 Process for the measurement of the potency of glatiramer acetate
US7655221B2 (en) 2004-05-07 2010-02-02 Peptimmune, Inc. Methods of treating disease with random copolymers
CN111704651B (en) * 2020-07-27 2021-10-08 南京安吉生物科技有限公司 Polypeptide RV3 and RV4 with anti-aging effect and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3514587A1 (en) * 1985-04-23 1986-10-30 Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl PHARMACOLOGICALLY ACTIVE PEPTIDES
WO1990008161A1 (en) * 1989-01-12 1990-07-26 The Blood Center Of Southeastern Wisconsin Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses

Also Published As

Publication number Publication date
IL99008A0 (en) 1992-07-15
WO1992002543A1 (en) 1992-02-20
PT98501A (en) 1992-05-29
MX9100454A (en) 1992-04-01
IE912701A1 (en) 1992-02-12

Similar Documents

Publication Publication Date Title
AU8305491A (en) Novel immunosuppressant peptides
AU9065891A (en) Novel renin inhibiting peptides
AU639126B2 (en) Oxorapamycin
AU8791591A (en) Tnf-muteins
AU7846991A (en) Aminobenzodiazepines
AU8676291A (en) Cyclopeptides
EP0448099A3 (en) Novel peptides
AU9030991A (en) Improved capacitor-sensor
AU7804691A (en) N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas
AU7956191A (en) Transportsystem
AU3977589A (en) Novel peptides
AU7726391A (en) Slitterscorer
AU610900B2 (en) Immunosuppressant peptides
AU7203691A (en) An umbrella
AU8228591A (en) Antimicrobial peptides
ZA915978B (en) Peptides
AU7566691A (en) Compostor
AU8740291A (en) 3d-spectacles
AU9118891A (en) Conformationally constrained peptides i
AU9171791A (en) N-protected aminoalkylaldehydes
AU7587991A (en) Electrodermatome
AU8516291A (en) Instant photograph-postcard
AU8984191A (en) Thiadiazinones
AU8490691A (en) Umbrella
EP0517916A4 (en) Immunosuppressant